Activation and inhibition of sirtuins: From bench to bedside

Francesco Fiorentino1, Emanuele Fabbrizi1, Antonello Mai1,2

  • 1Department of Drug Chemistry and Technologies, Sapienza University of Rome, Rome, Italy.

PubMed

Insights

Sirtuins, NAD+-dependent enzymes, regulate key cellular processes and aging. Modulating sirtuins offers therapeutic potential for metabolic, cardiovascular, and neurodegenerative diseases, and cancer.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Sirtuins are NAD+-dependent enzymes regulating genomic stability, gene expression, metabolism, and aging.
  • Dysregulation of sirtuins is implicated in metabolic, cardiovascular, neurological diseases, and cancer.
  • Sirtuins exhibit context-dependent roles in cancer, acting as tumor suppressors or promoters.

Purpose of the Study:

  • To provide critical insights into sirtuin pharmacology, enzymatic activities, and biological functions.
  • To review relevant sirtuin modulators, including their mechanisms, structure-activity relationships, and effects.
  • To discuss the therapeutic potential of sirtuin modulation in age-related diseases and cancer.

Main Methods:

  • Literature review of sirtuin biology and pharmacology.
  • Analysis of enzymatic activities and biological functions of sirtuins.
  • Overview of structure-activity relationships and pharmacological effects of sirtuin modulators.

Main Results:

  • Sirtuins are crucial for cellular homeostasis and organism wellness.
  • Sirtuin modulation shows therapeutic promise for diabetes, cardiovascular/neurodegenerative disorders, and cancer.
  • Isoform-selective modulators can advance understanding of sirtuin biology and therapeutic development.

Conclusions:

  • Sirtuin modulators represent a promising therapeutic strategy for various diseases.
  • Further research into isoform-selective sirtuin modulators is warranted.
  • Understanding sirtuin pharmacology is key to developing effective treatments for age-related conditions and cancer.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K